Unpicking the tangled symptomatology of COVID19 using an interpretable clustering methodology
Amanda Cooper, Alison Bourke(Amgen (United States)), Natalia Petruski‐Ivleva(AVEO Oncology (United States)), Oran Doyle
Pharmacoepidemiology and Drug Safety
January 1, 2021
Cited by 0
Related Papers
Dietary Protein Sources and Risk for Incident Chronic Kidney Disease: Results From the Atherosclerosis Risk in Communities (ARIC) Study
|Journal of Renal Nutrition|2017|254
Incidence, prevalence and mortality of IgG4-related disease in the USA: a claims-based analysis of commercially insured adults
|Annals of the Rheumatic Diseases|2023|95
Depression, Anxiety, and Self-Directed Violence in Women With Endometriosis: A Retrospective Matched-Cohort Study
|American Journal of Epidemiology|2020|66